Protexa Therapeutics is Drug Discovery in United Kingdom that focus on lead product business. Founded in 2008. They cover business area such as developer, proprietary pharmaceutical product, TGF-beta production stimulator, droloxifene, clopidogrel, cardiovascular disease, particular acute coronary syndrome.
2008
( 18 years old in 2026 )
Lead Product
-
9 St Johns Street
Cambridgeshire
Duxford CB22 4RA
England, United Kingdom
Private
developerproprietary pharmaceutical productTGF-beta production stimulatordroloxifeneclopidogrelcardiovascular diseaseparticular acute coronary syndrome
* We use standard office opening hours in near Protexa Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Protexa Therapeutics is Drug Discovery business from United Kingdom that founded in 2008 (18 years old in 2026), Protexa Therapeutics business is focusing on Lead Product.
Protexa Therapeutics headquarter office and corporate office address is located in 9 St Johns Street Cambridgeshire Duxford CB22 4RA England, United Kingdom.
Protexa Therapeutics was founded in United Kingdom.
In 2026, Protexa Therapeutics is currently focus on lead product sector.
Above is snippet of Google Trends for "lead product" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Protexa Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
